Literature DB >> 24477553

Periostin and its emerging role in systemic carcinogenesis.

S Kapoor1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24477553     DOI： 10.1007/s00198-013-2614-0

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  10 in total

1.  Characterization of periostin isoform pattern in non-small cell lung cancer.

Authors:  Laura Morra; Markus Rechsteiner; Silvia Casagrande; Adriana von Teichman; Peter Schraml; Holger Moch; Alex Soltermann
Journal:  Lung Cancer       Date:  2011-11-12       Impact factor: 5.705

Review 2.  The multiple facets of periostin in bone metabolism.

Authors:  B Merle; P Garnero
Journal:  Osteoporos Int       Date:  2012-02-07       Impact factor: 4.507

3.  Periostin activates integrin α5β1 through a PI3K/AKT‑dependent pathway in invasion of cholangiocarcinoma.

Authors:  Kusumawadee Utispan; Jumaporn Sonongbua; Peti Thuwajit; Siri Chau-In; Chawalit Pairojkul; Sopit Wongkham; Chanitra Thuwajit
Journal:  Int J Oncol       Date:  2012-06-25       Impact factor: 5.650

4.  Role of periostin in cancer progression and metastasis: inhibition of breast cancer progression and metastasis by anti-periostin antibody in a murine model.

Authors:  Mariko Kyutoku; Yoshiaki Taniyama; Naruto Katsuragi; Hideo Shimizu; Yasuo Kunugiza; Kazuma Iekushi; Nobutaka Koibuchi; Fumihiro Sanada; Yoshihiro Oshita; Ryuichi Morishita
Journal:  Int J Mol Med       Date:  2011-05-26       Impact factor: 4.101

5.  Periostin, a matrix protein, has potential as a novel serodiagnostic marker for cholangiocarcinoma.

Authors:  Kiminori Fujimoto; Takumi Kawaguchi; Osamu Nakashima; Junya Ono; Shoichiro Ohta; Atsushi Kawaguchi; Tatsuyuki Tonan; Koichi Ohshima; Hirohisa Yano; Naofumi Hayabuchi; Kenji Izuhara; Michio Sata
Journal:  Oncol Rep       Date:  2011-02-23       Impact factor: 3.906

6.  Periostin, a stroma-associated protein, correlates with tumor invasiveness and progression in nasopharyngeal carcinoma.

Authors:  Meixiang Li; Cui Li; Danjuan Li; Yuanjie Xie; Jinfeng Shi; Guoqing Li; Yongjun Guan; Maoyu Li; Pengfei Zhang; Fang Peng; Zhiqiang Xiao; Zhuchu Chen
Journal:  Clin Exp Metastasis       Date:  2012-06-17       Impact factor: 5.150

7.  Collagen triple helix repeat containing 1 protein, periostin and versican in primary and metastatic breast cancer: an immunohistochemical study.

Authors:  Gvantsa Kharaishvili; Magdalena Cizkova; Katerina Bouchalova; Giorgi Mgebrishvili; Zdenek Kolar; Jan Bouchal
Journal:  J Clin Pathol       Date:  2011-07-08       Impact factor: 3.411

8.  Cancer stem cell-related gene periostin: a novel prognostic marker for breast cancer.

Authors:  Dongyang Xu; Hong Xu; Ying Ren; Caigang Liu; Xuemei Wang; Hao Zhang; Ping Lu
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

9.  Periostin: a promising target of therapeutical intervention for prostate cancer.

Authors:  Chuanyu Sun; Xiaojun Zhao; Ke Xu; Jian Gong; Weiwei Liu; Weihong Ding; Yuancheng Gou; Guowei Xia; Qiang Ding
Journal:  J Transl Med       Date:  2011-06-30       Impact factor: 5.531

10.  Periostin directly and indirectly promotes tumor lymphangiogenesis of head and neck cancer.

Authors:  Yasusei Kudo; Shinji Iizuka; Maki Yoshida; Phuong Thao Nguyen; Samadarani B S M Siriwardena; Takaaki Tsunematsu; Mariko Ohbayashi; Toshinori Ando; Daijiro Hatakeyama; Toshiyuki Shibata; Keiichi Koizumi; Masahiro Maeda; Naozumi Ishimaru; Ikuko Ogawa; Takashi Takata
Journal:  PLoS One       Date:  2012-08-30       Impact factor: 3.240
  10 in total
  1 in total

1.  High levels of periostin correlate with increased fracture rate, diffuse MRI pattern, abnormal bone remodeling and advanced disease stage in patients with newly diagnosed symptomatic multiple myeloma.

Authors:  E Terpos; D Christoulas; E Kastritis; T Bagratuni; M Gavriatopoulou; M Roussou; A Papatheodorou; E Eleutherakis-Papaiakovou; N Kanellias; C Liakou; I Panagiotidis; M Migkou; P Kokkoris; L A Moulopoulos; M A Dimopoulos
Journal:  Blood Cancer J       Date:  2016-10-07       Impact factor: 11.037
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.